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State newborn screening programs are essential to pro-
tect the health of children. Moreover, blood-spot card
stocks and, in general, collections of biological speci-
mens have a significant research potential. Children are
a vulnerable research population, as they lack the capa-
city for consenting to their participation. However,
unlike members of such other populations, children’s
vulnerability is temporary and does not arise from a dis-
order: most children will become healthy adults. There-
fore, paediatric biobanks raises unique ethical issues:
parental authorization, assent and consent of the child
when he will mature the capacity to make independent
decisions, degree of communication required with the
parents and the child, new use of data and/or samples
collected previously, potentially lengthy period of sto-
rage, long-term studies, withdrawal from storage and/or
research, return of results, and others. Codes, guidelines
and policy documents from national (e.g.: National
Bioethics Committees), international and supranational
(e.g.: OECD, UNESCO, WHO, WMA, European Union,
Council of Europe) institutions are available. These
documents give important guidance but clear-cut
national policies are needed for the inclusion of chil-
dren’s biological specimens in population biobanks: lack
of openness may lead to the loss of public trust in
research.
In Italy neonatal screening program has been manda-
tory for congenital hypothyroidism, cystic fibrosis, and
phenylketonuria since 1992. Moreover, on the basis of
regional laws other screening programs for endocrinopa-
thies and inborn errors of metabolism are performed in
some Italian Regions. This implies that every year about
550,000 dried blood spot cards from all Italian newborns
are collected and analyzed in the 32 Screening Centers
active in our country.
After newborn screening has been completed many
screening laboratories retain the residual dried blood
samples (DBS) for various purposes, including program
evaluation, quality assurance, and biomedical research.
In 2006 the Italian Society for the Study of Metabolic
Diseases and Neonatal Screening (SIMMESN) recom-
mended a storage of at least 5 years protecting privacy
of newborns and their families. However, a more recent
survey performed by the SIMMESN revealed a signifi-
cant dishomogeneity among screening laboratories in
the management of residual DBS in terms of time of
retention, requirement of parental consent, and use of
the samples.
Because of this huge variability and to achieve an
appropriate balance between respecting the rights of
newborns and their parents versus the potential for pub-
lic good deriving from the use of DBS for research pur-
poses, the Joint Group National Committee of Bioethics
- National Committee for Biosafety Biotechnologies and
Life Sciences have recommended developing a National
Network of Regional Newborn Screening Repositories
for collection of residual DBS, coordinated by the Italian
National Institute of Health [1].
In particular, the Joint Group recommends:
- to overcome some current organisational problems
of neonatal screening (number of screened babies per
screening center, cut-off values, recall index, analytical
strategies of selection, efficiency index, etc.);
- to reconsider the regulations for the compulsory
short-term/medium-term preservation of the samples, in
the newborn’s medical - legal interest;
- to establish long-term collections of residual material
from compulsory neonatal screening;
- to safeguard, with adequate regulations, the current
collections present in some neonatal screening Centres
to avoid their deterioration or destruction;
- to promote the training of the staff operating in the
various Centres, with regards to not only the “technical”
care of the samples (correct collection, correct use,
appropriate preservation, etc.), but also of the rights of
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the newborn, child and family, inherent to appropriate
information, confidentiality, personal data protection
and privacy.
The establishment of a national network of regional
repositories implies adopting uniform criteria for long-
term retention and for an effective education for parents
about DBS and control over their retention and use.
The latter point is relevant because the maintenance of
public trust in such an initiative is crucial and can be
obtained only by making public aware of the potential
for public health deriving from the use of residual DBS
for research purposes.
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